Using informative features in machine learning based method for COVID-19 drug repurposing.

Aghdam R, Habibi M, Taheri G

J Cheminform 13 (1) 70 [2021-09-20; online 2021-09-20]

Coronavirus disease 2019 (COVID-19) is caused by a novel virus named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This virus induced a large number of deaths and millions of confirmed cases worldwide, creating a serious danger to public health. However, there are no specific therapies or drugs available for COVID-19 treatment. While new drug discovery is a long process, repurposing available drugs for COVID-19 can help recognize treatments with known clinical profiles. Computational drug repurposing methods can reduce the cost, time, and risk of drug toxicity. In this work, we build a graph as a COVID-19 related biological network. This network is related to virus targets or their associated biological processes. We select essential proteins in the constructed biological network that lead to a major disruption in the network. Our method from these essential proteins chooses 93 proteins related to COVID-19 pathology. Then, we propose multiple informative features based on drug-target and protein-protein interaction information. Through these informative features, we find five appropriate clusters of drugs that contain some candidates as potential COVID-19 treatments. To evaluate our results, we provide statistical and clinical evidence for our candidate drugs. From our proposed candidate drugs, 80% of them were studied in other studies and clinical trials.

Category: Health

Category: Other

Type: Journal article

PubMed 34544500

DOI 10.1186/s13321-021-00553-9

Crossref 10.1186/s13321-021-00553-9

pii: 10.1186/s13321-021-00553-9
pmc: PMC8451172


Publications 7.0.1